295 related articles for article (PubMed ID: 16324129)
1. Corticostriatal functional interactions in Parkinson's disease: a rTMS/[11C]raclopride PET study.
Strafella AP; Ko JH; Grant J; Fraraccio M; Monchi O
Eur J Neurosci; 2005 Dec; 22(11):2946-52. PubMed ID: 16324129
[TBL] [Abstract][Full Text] [Related]
2. Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex.
Strafella AP; Paus T; Fraraccio M; Dagher A
Brain; 2003 Dec; 126(Pt 12):2609-15. PubMed ID: 12937078
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: the contribution of expectation.
Strafella AP; Ko JH; Monchi O
Neuroimage; 2006 Jul; 31(4):1666-72. PubMed ID: 16545582
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of repetitive transcranial magnetic stimulation in Parkinson's disease: analysis of [11C] raclopride PET study.
Kim JY; Chung EJ; Lee WY; Shin HY; Lee GH; Choe YS; Choi Y; Kim BJ
Mov Disord; 2008 Jan; 23(2):207-11. PubMed ID: 17999422
[TBL] [Abstract][Full Text] [Related]
5. Theta burst stimulation-induced inhibition of dorsolateral prefrontal cortex reveals hemispheric asymmetry in striatal dopamine release during a set-shifting task: a TMS-[(11)C]raclopride PET study.
Ko JH; Monchi O; Ptito A; Bloomfield P; Houle S; Strafella AP
Eur J Neurosci; 2008 Nov; 28(10):2147-55. PubMed ID: 19046396
[TBL] [Abstract][Full Text] [Related]
6. Endogenous dopamine release induced by repetitive transcranial magnetic stimulation over the primary motor cortex: an [11C]raclopride positron emission tomography study in anesthetized macaque monkeys.
Ohnishi T; Hayashi T; Okabe S; Nonaka I; Matsuda H; Iida H; Imabayashi E; Watabe H; Miyake Y; Ogawa M; Teramoto N; Ohta Y; Ejima N; Sawada T; Ugawa Y
Biol Psychiatry; 2004 Mar; 55(5):484-9. PubMed ID: 15023576
[TBL] [Abstract][Full Text] [Related]
7. Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.
Tedroff J; Pedersen M; Aquilonius SM; Hartvig P; Jacobsson G; Långström B
Neurology; 1996 May; 46(5):1430-6. PubMed ID: 8628494
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C] raclopride and [11C]N-methylspiperone.
Kaasinen V; Ruottinen HM; Någren K; Lehikoinen P; Oikonen V; Rinne JO
J Nucl Med; 2000 Jan; 41(1):65-70. PubMed ID: 10647606
[TBL] [Abstract][Full Text] [Related]
9. Effect of simple motor performance on regional dopamine release in the striatum in Parkinson disease patients and healthy subjects: a positron emission tomography study.
Ouchi Y; Yoshikawa E; Futatsubashi M; Okada H; Torizuka T; Sakamoto M
J Cereb Blood Flow Metab; 2002 Jun; 22(6):746-52. PubMed ID: 12045673
[TBL] [Abstract][Full Text] [Related]
10. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus.
Strafella AP; Paus T; Barrett J; Dagher A
J Neurosci; 2001 Aug; 21(15):RC157. PubMed ID: 11459878
[TBL] [Abstract][Full Text] [Related]
11. Effects of repetitive transcranial magnetic stimulation on [11C]raclopride binding and cognitive function in patients with depression.
Kuroda Y; Motohashi N; Ito H; Ito S; Takano A; Nishikawa T; Suhara T
J Affect Disord; 2006 Oct; 95(1-3):35-42. PubMed ID: 16781779
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study.
Nimura T; Yamaguchi K; Ando T; Shibuya S; Oikawa T; Nakagawa A; Shirane R; Itoh M; Tominaga T
J Neurosurg; 2005 Dec; 103(6):968-73. PubMed ID: 16381182
[TBL] [Abstract][Full Text] [Related]
13. Competition between 11C-raclopride and endogenous dopamine in Parkinson's disease.
Ishibashi K; Ishii K; Oda K; Mizusawa H; Ishiwata K
Nucl Med Commun; 2010 Feb; 31(2):159-66. PubMed ID: 19966595
[TBL] [Abstract][Full Text] [Related]
14. Exercise increases caudate dopamine release and ventral striatal activation in Parkinson's disease.
Sacheli MA; Neva JL; Lakhani B; Murray DK; Vafai N; Shahinfard E; English C; McCormick S; Dinelle K; Neilson N; McKenzie J; Schulzer M; McKenzie DC; Appel-Cresswell S; McKeown MJ; Boyd LA; Sossi V; Stoessl AJ
Mov Disord; 2019 Dec; 34(12):1891-1900. PubMed ID: 31584222
[TBL] [Abstract][Full Text] [Related]
15. Effect of sensory stimulus on striatal dopamine release in humans and cats: a [(11)C]raclopride PET study.
Thobois S; Hassoun W; Ginovart N; Garcia-Larrea L; Le Cavorsin M; Guillouet S; Bonnefoi F; Costes N; Lavenne F; Broussolle E; Leviel V
Neurosci Lett; 2004 Sep; 368(1):46-51. PubMed ID: 15342132
[TBL] [Abstract][Full Text] [Related]
16. Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: positron emission tomographic studies.
Koochesfahani KM; de la Fuente-Fernández R; Sossi V; Schulzer M; Yatham LN; Ruth TJ; Blinder S; Stoessl AJ
Mov Disord; 2006 Jul; 21(7):970-5. PubMed ID: 16570297
[TBL] [Abstract][Full Text] [Related]
17. Reduced striatal dopamine release during motor skill acquisition in Parkinson's disease.
Kawashima S; Ueki Y; Kato T; Ito K; Matsukawa N
PLoS One; 2018; 13(5):e0196661. PubMed ID: 29847548
[TBL] [Abstract][Full Text] [Related]
18. Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson's disease--A [(11)C]-raclopride PET study.
Thobois S; Fraix V; Savasta M; Costes N; Pollak P; Mertens P; Koudsie A; Le Bars D; Benabid AL; Broussolle E
J Neurol; 2003 Oct; 250(10):1219-23. PubMed ID: 14586606
[TBL] [Abstract][Full Text] [Related]
19. Incentive motivation is associated with striatal dopamine asymmetry.
Tomer R; Goldstein RZ; Wang GJ; Wong C; Volkow ND
Biol Psychol; 2008 Jan; 77(1):98-101. PubMed ID: 17868972
[TBL] [Abstract][Full Text] [Related]
20. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL
Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
